These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38644652)

  • 1. Efficacy and safety of generic cefoperazone/sulbactam versus branded cefoperazone/sulbactam in the treatment of bacterial infections: a systematic review and meta-analysis.
    Wu R; Wang X; Cui P; Chen W; Yang W; Lai Y
    J Chemother; 2024 Apr; ():1-11. PubMed ID: 38644652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Efficacy and Safety of Cefoperazone-Sulbactam in Treatment of Intra-Abdominal Infections: A Systematic Review and Meta-Analysis.
    Lan SH; Chao CM; Chang SP; Lu LC; Lai CC
    Surg Infect (Larchmt); 2021 Oct; 22(8):763-770. PubMed ID: 33625294
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness and Safety of Generic Formulation of Cefoperazone/Sulbactam (Bacticep®) in Treatment of Infections at Siriraj Hospital.
    Koomanachai P; Tongsai S; Thamlikitkul V
    J Med Assoc Thai; 2016 Jan; 99(1):8-14. PubMed ID: 27455819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of cefoperazone-sulbactam in empiric therapy for febrile neutropenia: A systemic review and meta-analysis.
    Lan SH; Chang SP; Lai CC; Lu LC; Tang HJ
    Medicine (Baltimore); 2020 Feb; 99(8):e19321. PubMed ID: 32080150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observation of clinical efficacy of the cefoperazone/sulbactam anti-infective regimen in the treatment of multidrug-resistant Acinetobacter baumannii lung infection.
    Wang Q; Huang M; Zhou S
    J Clin Pharm Ther; 2022 Jul; 47(7):1020-1027. PubMed ID: 35285526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.
    Li JT; Lu Y; Hou J; Chen YF; Miao JZ; Jia YX; Hou J; Zhang XZ; Chen DK; Hu WZ; Li LJ; Liu DM; Wang Z; Wu J; Gu JM; Wang HL; Zhang YL; Sun L
    Clin Infect Dis; 1997 Mar; 24(3):498-505. PubMed ID: 9114206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections.
    Xin X; Jian L; Xia X; Jia B; Huang W; Li C; Wang C; Zhou L; Sun X; Tang X; Huang Y; Zhu Y; Zhang W
    Ann Clin Microbiol Antimicrob; 2013 Dec; 12():38. PubMed ID: 24321187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized clinical study of cefoperazone and sulbactam versus gentamicin and clindamycin in the treatment of intra-abdominal infections.
    Jauregui LE; Appelbaum PC; Fabian TC; Hageage G; Strausbaugh L; Martin LF
    J Antimicrob Chemother; 1990 Mar; 25(3):423-33. PubMed ID: 2187014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia.
    Liu JW; Chen YH; Lee WS; Lin JC; Huang CT; Lin HH; Liu YC; Chuang YC; Tang HJ; Chen YS; Ko WC; Lu MC; Wang FD
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment efficacy of tigecycline in comparison to cefoperazone/ sulbactam alone or in combination therapy for carbapenenm-resistant Acinetobacter baumannii infections.
    Li Y; Xie J; Chen L; Meng T; Liu L; Hao R; Dong H; Wang X; Dong Y
    Pak J Pharm Sci; 2020 Jan; 33(1):161-168. PubMed ID: 32122844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of efficacy between ceftriaxone and cefoperazone plus sulbactam in peri-operative treatment of acute suppurative cholangitis].
    Zhou XS; Zou SQ; Dong JH; Wu WZ; Zhang YD; Zhang TL; Zeng Z; Li NF; Man GT
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1879-82. PubMed ID: 15631798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study on sulbactam/cefoperazone in urinary tract infections in elderly patients].
    Oyabu Y
    Jpn J Antibiot; 1996 Mar; 49(3):250-5. PubMed ID: 8935120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical efficacy of cefoperazone-sulbactam versus piperacillin-tazobactam in the treatment of severe community-acquired pneumonia.
    Lai CC; Chen WC; Kuo LK; Wang YT; Fu PK; Ku SC; Fang WF; Chen CM; Tu CY; Cheng WC; Chen CH
    Medicine (Baltimore); 2023 Jul; 102(28):e34284. PubMed ID: 37443505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model-Informed Drug Development of New Cefoperazone Sodium and Sulbactam Sodium Combination (3:1): Pharmacokinetic/Pharmacodynamic Analysis and Antibacterial Efficacy Against Enterobacteriaceae.
    Ji XW; Zhu X; Li Y; Xue F; Kuan IHS; He QF; Meng XR; Xiang XQ; Cui YM; Zheng B
    Front Pharmacol; 2022; 13():856792. PubMed ID: 35924047
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experience with the treatment of severe nosocomial infections by inhibitor-protected 3rd generation cephalosporin cefoperazone/sulbactam].
    Beloborodova NV; Kuznetsova ST; Popov DA; Bachinskaia EN; Vostrikov TIu
    Antibiot Khimioter; 2005; 50(4):33-40. PubMed ID: 16392338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness study comparing cefoperazone-sulbactam to a three-drug combination for treating intraabdominal infections in an Indian health-care setting.
    Kochhar P; Suvarna V; Duttagupta S; Sarkar S
    Value Health; 2008 Mar; 11 Suppl 1():S33-8. PubMed ID: 18387065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro activity of cefoperazone-sulbactam combination against cefoperazone resistant clinical isolates in a Malaysian general hospital.
    Lim VK; Cheong YM
    Malays J Pathol; 1995 Dec; 17(2):73-6. PubMed ID: 8935129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India.
    Chandra A; Dhar P; Dharap S; Goel A; Gupta R; Hardikar JV; Kapoor VK; Mathur AK; Modi P; Narwaria M; Ramesh MK; Ramesh H; Sastry RA; Shah S; Virk S; Sudheer OV; Sreevathsa MR; Varshney S; Kochhar P; Somasundaram S; Desai C; Schou M
    Surg Infect (Larchmt); 2008 Jun; 9(3):367-76. PubMed ID: 18570578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of empirical therapy with cefoperazone/sulbactam or a carbapenem for bloodstream infections due to ESBL-producing Enterobacteriaceae.
    Su J; Guo Q; Li Y; Wu S; Hu F; Xu S; Wang M
    J Antimicrob Chemother; 2018 Nov; 73(11):3176-3180. PubMed ID: 30099554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.